ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NPH Neuropharm

11.50
0.00 (0.00%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Neuropharm LSE:NPH London Ordinary Share GB00B1NPJJ01 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Interim Results -4-

23/03/2010 7:01am

UK Regulatory



| At 30 June     |   3,154 |  17,269 |   (607) |           - |          632 |  (7,790) |  12,658 | 
| 2008           |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
|                |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Share option   |       - |       - |       - |           - |          308 |        - |     308 | 
| expense        |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Reserve        |       - |       - |       - |           - |            - |        - |       - | 
| transfer       |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Total          |       - |       - |       - |           - |            - |  (3,458) | (3,458) | 
| comprehensive  |         |         |         |             |              |          |         | 
| loss for the   |         |         |         |             |              |          |         | 
| period         |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
|                |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| At 31 December |   3,154 |  17,269 |   (607) |           - |          940 | (11,248) |   9,508 | 
| 2008           |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
|                |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Share option   |       - |       - |       - |           - |          142 |        - |     142 | 
| expense        |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Foreign        |       - |       - |       - |          33 |            - |        - |      33 | 
| exchange       |         |         |         |             |              |          |         | 
| adjustments on |         |         |         |             |              |          |         | 
| consolidation  |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Total          |       - |       - |       - |           - |            - |  (2,426) | (2,426) | 
| comprehensive  |         |         |         |             |              |          |         | 
| loss for the   |         |         |         |             |              |          |         | 
| period         |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
|                |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| At 30 June     |   3,154 |  17,269 |   (607) |          33 |        1,082 | (13,674) |   7,257 | 
| 2009           |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
|                |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Share option   |       - |       - |       - |           - |           91 |        - |      91 | 
| expense        |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Foreign        |       - |       - |       - |           4 |            - |        - |       4 | 
| exchange       |         |         |         |             |              |          |         | 
| adjustments on |         |         |         |             |              |          |         | 
| consolidation  |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| Total          |       - |       - |       - |           - |            - |  (1,225) | (1,225) | 
| comprehensive  |         |         |         |             |              |          |         | 
| loss for the   |         |         |         |             |              |          |         | 
| period         |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
|                |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
| At 31 December |   3,154 |  17,269 |   (607) |          37 |        1,173 | (14,899) |   6,127 | 
| 2009           |         |         |         |             |              |          |         | 
+----------------+---------+---------+---------+-------------+--------------+----------+---------+ 
 
 
 
+------------------------------------+------+--+----------+----------+----------+ 
|                                                                               | 
| Consolidated Balance Sheet                                                    | 
| Six months ended 31 December 2009                                             | 
|                                                                               | 
+-------------------------------------------------------------------------------+ 
|                                    |Note  |  |   31 Dec |   31 Dec |       30 | 
|                                    |      |  |     2009 |     2008 |     June | 
|                                    |      |  |  GBP'000 |  GBP'000 |     2009 | 
|                                    |      |  |          |          |  GBP'000 | 
+------------------------------------+------+--+----------+----------+----------+ 
|                                    |      |  |          |          |          | 
+------------------------------------+------+--+----------+----------+----------+ 
| Non-current assets                 |      |  |          |          |          | 
+------------------------------------+------+--+----------+----------+----------+ 
| Intangible assets                  |  6   |  |        - |        - |        - | 
+------------------------------------+------+--+----------+----------+----------+ 
| Property, plant and equipment      |  7   |  |       11 |       16 |       16 | 
+------------------------------------+------+--+----------+----------+----------+ 
|                                    |      |  |       11 |       16 |       16 | 
+------------------------------------+------+--+----------+----------+----------+ 
| Current assets                     |      |  |          |          |          | 
+------------------------------------+------+--+----------+----------+----------+ 
| Accrued income and margin deposits |      |  |        - |      180 |       63 | 
+------------------------------------+------+--+----------+----------+----------+ 
| Trade and other receivables        |      |  |      145 |      182 |       95 | 
+------------------------------------+------+--+----------+----------+----------+ 
| Derivative financial instruments   |      |  |        - |      150 |        - | 
+------------------------------------+------+--+----------+----------+----------+ 
| Research and development tax credits      |  |        - |        - |      600 | 
| receivable                                |  |          |          |          | 
+-------------------------------------------+--+----------+----------+----------+ 
| Money market investments           |      |  |        - |    6,500 |    1,000 | 
+------------------------------------+------+--+----------+----------+----------+ 
| Cash and cash equivalents          |      |  |    6,182 |    3,676 |    6,037 | 
+------------------------------------+------+--+----------+----------+----------+ 
|                                    |      |  |    6,327 |   10,688 |    7,795 | 
+------------------------------------+------+--+----------+----------+----------+ 
| Current liabilities                |      |  |          |          |          | 
+------------------------------------+------+--+----------+----------+----------+ 
| Trade and other payables           |      |  |    (211) |  (1,144) |    (554) | 
+------------------------------------+------+--+----------+----------+----------+ 
| Net current assets                 |      |  |    6,116 |    9,544 |    7,241 | 
+------------------------------------+------+--+----------+----------+----------+ 
| Total assets less current          |      |  |    6,127 |    9,560 |    7,257 | 
| liabilities                        |      |  |          |          |          | 
+------------------------------------+------+--+----------+----------+----------+ 
|                                    |      |  |          |          |          | 
+------------------------------------+------+--+----------+----------+----------+ 

1 Year Neuropharm Chart

1 Year Neuropharm Chart

1 Month Neuropharm Chart

1 Month Neuropharm Chart

Your Recent History

Delayed Upgrade Clock